[11] [11] CAI T, AL-JUBAIRI N N, SANTOS H 0, et al. Does letrozole treatment have favorable effects on the lipid profile? A systematic review and meta-analysis of randomized clinical trials[J]. Steroids, 2021, 172: 108875.

[14] [14] MAURAS N, ROSS J, MERICQ V. Management of growth disorders in puberty: GH, GnRHa, and aromatase inhibitors: a clinical review[J]. Endocr Rev, 2023, 44(1): 1-13.

[16] [16] COHEN L E, ROGOL A D. Children with idiopathic short stature: an expanding role for genetic investigation in their medical evaluation[J]. Endocr Pract, 2024, 30(7): 679-686.

[19] [19] HODAX J K, TOPOR L S, BIALO S R, et al. Anastrozole improves final adult height in severe hypothyroidism with rapid pubertal progression[J]. J Endocr Soc, 2021, 5(5): bvab025.

[20] [20] TORRES-SANTIAGO L, MAURAS N. Approach to the peripubertal patient with short stature[J]. J Clin Endocrinol Metab, 2024, 109(7): e1522-e1533.

[21] [21] SALIM A A, KAWASOE S, KUBOZONO T, et al. Abstract 11758: sex differences in the associations between uric acid and incidence of hypertension, diabetes, and chronic kidney disease in a healthy Japanese population[J]. Circulation, 2022, 146 (Suppl_1): 3.

[22] [22] XU Y, ZHANG Y H, ZHANG Q P, et al. Off-label use of letrozole in Chinese short pubertal boys: Effectiveness, safety, and exposure-response analysis[J]. Br J Clin Pharmacol, 2021, 87(9): 3599-3607.

[23] [23] MA Y P, JIA R F, XIA B Y, et al. Adult height in pubertal boys with short stature treated with GH/letrozole: a hospital record-based retrospective study[J]. BMC Pediatr, 2022, 22(1): 371.

[24] [24] XIANG Q, LI L, JI W, et al. Beyond resorption: osteoclasts as drivers of bone formation[J]. Cell Regen, 2024, 13(1): 22.

[25] [25] GANDHI S, BULLOCK C A, RITZ E M, et al. Aromatase inhibitor induced bone loss: do international guidelines accurately stratify fracture risk and selection of anti-osteoporosis treatment?[J]. J Endocr Soc, 2021, 5(Supplement_1): A242.

[26] [26] HU J H, XU W Y, YANG H Y, et al. Uric acid participating in female reproductive disorders: a review[J]. Reprod Biol Endocrinol, 2021, 19(1): 65.

[27] [27] CHEN L H, CHOU C L, YANG C R, et al. Multiomics analyses reveal sex differences in mouse renal proximal subsegments[J]. J Am Soc Nephrol, 2023, 34(5): 829-845.

[28] [28] MILLS E L, HARMON C, JEDRYCHOWSKI M P, et al. Cysteine 253 of UCP1 regulates energy expenditure and sex-dependent adipose tissue inflammation[J]. Cell Metab, 2022, 34(1): 140-157. e8.

[29] [29] PERTICONE M, MAIO R, SHEHAJ E, et al. Sex-related differences for uric acid in the prediction of cardiovascular events in essential hypertension. A population prospective study[J]. Cardiovasc Diabetol, 2023, 22(1): 298.